Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Billionaire Stanley Druckenmiller Has Roughly 17% of His $5.2 Billion Duquesne Portfolio in Natera Stock. Is It Still a Buy After an 80% Run?

The billionaire has good reasons to like this genetic testing leader.

Billionaire Stanley Druckenmiller Has Roughly 17% of His $5.2 Billion Duquesne Portfolio in Natera Stock. Is It Still a Buy After an 80% Run?

Published August 29, 2026 · Category: Finance

Overview

Some investors throw money at lots of stocks and hope that enough become winners to offset the inevitable losers. That isn't the approach Stanley Druckenmiller takes. The billionaire only invests in high-conviction stocks after a thorough analysis.

Druckenmiller's Duquesne Family Office currently owns 90 stocks. But 16.6% of the portfolio is invested in only one stock -- Natera (NASDAQ: NTRA). This genomics stock has skyrocketed roughly 80% since its year-to-date low on May 15, 2026. Is Natera still a buy?

Stanley Druckenmiller. Image source: Getty Images.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.